ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1165

Macrophage-Derived Cytokine Mediation of Kidney-Lung Bidirectionally, Deleterious, Interorgan Cross-Talk in Kidney Fibrosis

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Bhatia, Divya, Weill Cornell Medicine, New York, New York, United States
  • Patiño, Edwin, Weill Cornell Medicine, New York, New York, United States
  • Kallinos, Eleni, Weill Cornell Medicine, New York, New York, United States
  • Plataki, Maria, Weill Cornell Medicine, New York, New York, United States
  • Muthukumar, Thangamani, Weill Cornell Medicine, New York, New York, United States
  • Choi, Augustine MK, Weill Cornell Medicine, New York, New York, United States
  • Choi, Mary E., Weill Cornell Medicine, New York, New York, United States
Background

The mechanism underlying kidney-lung interaction during chronic kidney disease (CKD) remains understudied. We investigated mitofusin (MFN)1 and MFN2 roles in modulating lung macrophage-derived immune signals during kidney fibrosis in animal models. In patients with interstitial fibrosis and tubular atrophy (IFTA), we examined the association of circulating and urinary macrophage-derived cytokines with biomarkers of kidney function.

Methods

Myeloid-(LysM-Cre+/-) or type 2 alveolar epithelial cell (AEC2; Spc-Cre+/-)-specific Mfn1+/- and/or Mfn2+/- and control mice were subjected to unilateral ureteral obstruction (UUO) or sham surgery (7-days), or adenine (AD) or control (Ctl) diet (4 or 8-weeks). Lungs, kidneys, and bronchoalveolar lavage fluid were analyzed. Blood was immunophenotyped and assessed for chemokines, blood urea nitrogen (BUN), and creatinine. Circulating and urinary macrophage-derived cytokines and kidney function panel were analyzed in patients with (n=7) or without (n=9) IFTA by bead array.

Results

AEC2 but not myeloid-specific Mfn1/2 loss promoted kidney fibrosis-associated lung injury, monocytes/macrophages, their galectin-3 expression, and oxidative stress in the lungs. AEC2-specific Mfn1+/-/Mfn2+/- ablation increased circulating levels of macrophage-derived cytokines (CCL17, CCL22, TGF-β1, IL-12p40), inflammatory monocytes (Ly6Chigh, CD11b) with enhanced migratory (CCR2) abilities, BUN and creatinine after UUO. AEC2-specific Mfn1+/-/Mfn2+/- deficiency induced UUO-mediated kidney fibrosis, frequency of kidney macrophages, and their profibrotic responses. Patients with IFTA had significantly increased circulating CCL17, IL-12p40, IL-12p70, and IL-6 levels. In patients with IFTA: a) circulating levels of IL-12p19 and IL-12p40 complex positively associated with osteopontin; b) glomerular filtration rate was negatively associated with plasma trefoil factor 3 and cystatin C; and c) urinary cystatin C was positively associated with CXCL10 and IL-6 levels.

Conclusion

During CKD, inflammatory macrophages negatively impact mitochondrial functions of AEC2, which then promote lung macrophage-derived inflammation. Lung macrophage-derived cytokines in turn aggravate kidney fibrosis by favoring migration of pro-inflammatory monocytes to the kidney in a bidirectional manner.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)